Cargando…

Preoperative neoadjuvant chemoradiotherapy provides borderline resectable thoracic esophageal cancer with equivalent treatment results as clinically T3 thoracic esophageal cancer

AIM: Because the optimal treatment strategy for borderline resectable (cT3br) thoracic esophageal cancer patients remains unclear, it is of great interest whether preoperative neoadjuvant therapy for cT3br could achieve results comparable to those seen with resectable T3 cancer (cT3r). We speculated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wakita, Akiyuki, Motoyama, Satoru, Sato, Yusuke, Nagaki, Yushi, Fujita, Hiromu, Kemuriyama, Kohei, Hayashi, Kenjiro, Imai, Kazuhiro, Nanjo, Hiroshi, Minamiya, Yoshihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623951/ https://www.ncbi.nlm.nih.gov/pubmed/37927919 http://dx.doi.org/10.1002/ags3.12706

Ejemplares similares

Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy
por: Nagaki, Yushi, et al.
Publicado: (2021)

Salvage esophagectomy under bilateral thoracotomy after definitive chemoradiotherapy for aorta T4 thoracic esophageal squamous cell carcinoma: Report of a case
por: Nagaki, Yushi, et al.
Publicado: (2015)

Evaluation of metastatic lymph nodes in cN0 thoracic esophageal cancer patients with inconsistent pathological lymph node diagnosis
por: Wakita, Akiyuki, et al.
Publicado: (2020)

Differences in treatment and survival between elderly patients with thoracic esophageal cancer in metropolitan areas and other areas
por: Motoyama, Satoru, et al.
Publicado: (2021)

Lower local recurrence rate after robot-assisted thoracoscopic esophagectomy than conventional thoracoscopic surgery for esophageal cancer
por: Motoyama, Satoru, et al.
Publicado: (2021)

Salvage Robotic-Assisted Thoracoscopic Esophagectomy after Definitive Chemoradiotherapy for Clinical T4b Esophageal Cancer: A Case Report
por: Sasamori, Ryohei, et al.
Publicado: (2021)

SUV(max) reduction predicts long-term survival in patients of non-pCR both in the tumor and lymph nodes after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma
por: Nagaki, Yushi, et al.
Publicado: (2021)

Robot-assisted thoracoscopic enucleation for a large esophageal leiomyoma: a case report
por: Kemuriyama, Kohei, et al.
Publicado: (2021)

Neoadjuvant Chemoradiotherapy Followed by Esophagectomy with Three-Field Lymph Node Dissection for Thoracic Esophageal Squamous Cell Carcinoma Patients with Clinical Stage III and with Supraclavicular Lymph Node Metastasis
por: Sato, Yusuke, et al.
Publicado: (2021)

High TLR6 Expression Status Predicts a More Favorable Prognosis after Esophagectomy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
por: Sato, Yusuke, et al.
Publicado: (2023)

Comparison of the incidences of anastomotic leakage when PDSII or LACLON are used in esophago-gastric conduit handsewn anastomosis after esophagectomy
por: Sato, Yusuke, et al.
Publicado: (2020)

Two cases of cisplatin-induced permanent renal failure following neoadjuvant chemotherapy for esophageal cancer
por: Sasaki, Tomohiko, et al.
Publicado: (2016)

Association of Chemoradiotherapy With Thoracic Vertebral Fractures in Patients With Esophageal Cancer
por: Fujii, Kota, et al.
Publicado: (2020)

Surgical therapy for breast cancer liver metastases
por: Terata, Kaori, et al.
Publicado: (2020)

Loco-regional therapy for isolated locoregional lymph node recurrence of breast cancer: focusing on surgical treatment with combined therapy
por: Terata, Kaori, et al.
Publicado: (2020)

Neoadjuvant chemoradiotherapy plus surgery in the treatment of potentially resectable thoracic esophageal squamous cell carcinoma
por: Yan, Mao-Hui, et al.
Publicado: (2020)

Oncological and physiological impact of thoracic duct resection in esophageal cancer
por: Matsuda, Satoru, et al.
Publicado: (2023)

McKeown esophagectomy for a thoracic esophageal carcinoma patient who has a history of definitive chemoradiotherapy for esophageal carcinoma and total pharyngolaryngectomy for hypopharyngeal cancer
por: Sugawara, Kotaro, et al.
Publicado: (2023)

Neoadjuvant treatment strategy for locally advanced thoracic esophageal cancer
por: Mayanagi, Shuhei, et al.
Publicado: (2019)

Salvage esophagectomy with pancreatectomy for local recurrence of thoracic esophageal cancer after definitive chemoradiotherapy: A case report
por: Nishiwaki, Noriyuki, et al.
Publicado: (2017)

A male with primary accessory breast carcinoma in an axilla is strongly suspected of having hereditary breast cancer
por: Takahashi, Eriko, et al.
Publicado: (2021)

TNM Staging Matched-pair Comparison of Surgery After Neoadjuvant Chemoradiotherapy, Surgery Alone and Definitive Chemoradiotherapy for Thoracic Esophageal Squamous Cell Carcinoma
por: Liu, ShiLiang, et al.
Publicado: (2017)

Surgical treatment of thoracic esophageal diverticula
por: Wlodarczyk, Janusz, et al.
Publicado: (2023)

Outcome Of Eras In Thoracic Esophageal Cancer Surgery In The Corona Disaster
por: Sato, H., et al.
Publicado: (2023)

Is There a Benefit in Receiving Concurrent Chemoradiotherapy for Elderly Patients with Inoperable Thoracic Esophageal Squamous Cell Carcinoma?
por: Zhang, Peng, et al.
Publicado: (2014)

Efficacy and prognostic analysis of chemoradiotherapy in patients with thoracic esophageal squamous carcinoma with cervical lymph nodal metastasis alone
por: Zhang, Peng, et al.
Publicado: (2014)

Past, present, and future of three‐field lymphadenectomy for thoracic esophageal cancer
por: Udagawa, Harushi
Publicado: (2020)

Comparison of the effects of radiotherapy doses of 50.4 Gy and 60 Gy on outcomes of chemoradiotherapy for thoracic esophageal cancer: subgroup analysis based on the Comprehensive Registry of Esophageal Cancer in Japan from 2009 to 2011 by the Japan Esophageal Society
por: Nemoto, Kenji, et al.
Publicado: (2020)

A prognostic nomogram for overall survival after neoadjuvant radiotherapy or chemoradiotherapy in thoracic esophageal squamous cell carcinoma: a retrospective analysis
por: Deng, Wei, et al.
Publicado: (2017)

Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Review of Meta-Analyses
por: Wijnhoven, Bas P. L., et al.
Publicado: (2009)

Neoadjuvant Chemoradiotherapy and Larynx-Preserving Surgery for Cervical Esophageal Cancer
por: Dai, Kun-Yao, et al.
Publicado: (2020)

Esophageal motion characteristics in thoracic esophageal cancer: Impact of clinical stage T4 versus stages T1-T3
por: Kobayashi, Yuta, et al.
Publicado: (2016)

Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study
por: Kawakami, Takeshi, et al.
Publicado: (2018)

Esophageal Perforation Accompanying Mediastinitis in Blunt Trauma in a Patient with Thoracic Osteophytes
por: Suzuki, Kei, et al.
Publicado: (2022)

A Pilot Study of Chemoradiotherapy With Weekly Docetaxel for Thoracic Esophageal Carcinoma With T4 and/or M1 Lymph Node Metastasis
por: Makino, Isamu, et al.
Publicado: (2011)

Postoperative Concurrent Chemoradiotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: A Phase II Clinical Trial
por: Li, Hui, et al.
Publicado: (2022)

Neck Dissection for Thoracic Esophageal Squamous Cell Carcinoma
por: Yajima, Satoshi, et al.
Publicado: (2012)

Descending thoracic aorta dissection associated with esophageal carcinoma
por: Saha, Kaushik, et al.
Publicado: (2013)

Is thoracic esophagostomy an option in esophageal perforation in pediatric patients?
por: Eroğlu, Atilla, et al.
Publicado: (2022)

Risk factors for pericardial effusion after chemoradiotherapy for thoracic esophageal cancer—comparison of four-field technique and traditional two opposed fields technique
por: Takata, Noriko, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jk83hfmc8jet00cibvesvgldar